Acute hepatitis C: prevention and treatment

@article{Ozaras2009AcuteHC,
  title={Acute hepatitis C: prevention and treatment},
  author={Resat Ozaras and Veysel Tahan},
  journal={Expert Review of Anti-infective Therapy},
  year={2009},
  volume={7},
  pages={351 - 361}
}
HCV can cause acute or chronic hepatitis and is a health problem all over the world. It is one of the leading causes of cirrhosis and hepatocellular carcinoma, and is a common indication for liver transplantation. Unrecognized patients with HCV infection may transmit the virus to uninfected people. The acute form of the disease leads to chronic hepatitis in the majority of cases. Since the success rate of treatment given in the chronic phase is much lower than that given in the acute phase… Expand
Management of Chronic Hepatitis C Virus Infection: Current Perspectives
TLDR
H hepatitis C virus infection leads to hepatic inflammation, steatosis, cirrhosis, and greater risk of hepatocellular carcinoma, and clinical manifestations include acute infection, chronic infection, non-hepatic complications, and occult infection. Expand
Hepatitis B and Hepatitis C viral infection: A Review
Hepatitis B viral infection is an infectiousinflammatory disease of the liver caused by the hepatitis B virus (HBV). The course of hepatitis B infection varies greatly, with the clinicalExpand
Occult Hepatitis C Infection Should Be More Noticed With New Treatment Strategies
TLDR
A condition that CHC cannot be diagnosed with the mentioned routine diagnostic tests is thought about and Imagine about dimensions of this condition on the health status of society. Expand
Early interferon-based treatment after detection of persistent hepatitis C virus infection: a critical decision.
TLDR
The cost-benefit analysis seems to indicate that in patients who are motivated and without contraindications, starting the treatment as early as possible is probably the best choice for success, and indeed, the final decision for starting treatment should be a case-by-case point. Expand
Hepatitis B, C, and Delta—Updates in Screening and Infection Prevention Opportunities for Eradication
TLDR
Although these drugs will not lead to the eradication of hepatitis C, they will significantly decrease the burden of this disease, avoiding the evolution for severe clinical pictures, such as liver cirrhosis, liver failure, and hepatocellular carcinoma. Expand
An overview on hepatitis C virus genotypes and its control
TLDR
To overcome the rate of HCV, guidance should be provided to make aware the persons about risk factors, transmission and prevention and to design new therapies and vaccines to overcome this disease. Expand
New Perspective in HCV Clinical and Economical Management of the Current and Future Therapies
TLDR
Even though new medications for hepatitis C are effective disease modifiers and have the potential, in a long term perspective, to eradicate the pathology, the cost of new treatments are unlikely to be sustainable for the NHSs. Expand
Assessing possible Different routes of HCV transmission
TLDR
This work aimed to detect possible other routes of HCV transmission using ELISA and western blotting techniques because body fluids other than blood might be potential sources ofHCV infection. Expand
The Association of Hepatitis C Serological Status with Several Risk Factors in Indonesia
TLDR
There is a correlation between hepatitis C serological status and demographic group and that the age and occupation groups showed significant P value obtained at 0.001, indicating risk factors such as age and occupations that have a correlation of being infected with hepatitis Cserological status. Expand
Incidence of Active HCV infection amongst Blood Donors of Mardan District, Pakistan.
TLDR
Application of strict measures during blood donor selection and use of proper screening assays such as ELISA in place of ICT devices can give a more accurate picture so that the incidence of this viral infection in HCV negative blood recipients can be reduced. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 140 REFERENCES
Acute hepatitis C virus infection: A chronic problem
TLDR
The current information regarding the understanding of the epidemiology, virology, and immunology of HCV with a particular emphasis on acute HCV infection is reviewed and an algorithm for the diagnosis and management of acute HCv infection is proposed. Expand
Acute Hepatitis C: A Systematic Review
  • S. Kamal
  • Medicine
  • The American Journal of Gastroenterology
  • 2008
TLDR
An improvement in the ability to diagnose and treat patients with acute hepatitis C would have a significant impact on the prevalence of chronic hepatitis and its associated complications particularly in countries with a high endemic background of the infection. Expand
Acute hepatitis C: current status and remaining challenges.
TLDR
The epidemiology of acute hepatitis C, its risk factors and routes of transmission and current treatment practices are discussed; the role of ribavirin has yet to be established. Expand
Hepatitis C: the clinical spectrum of the disease.
TLDR
While most patients with mild chronic hepatitis have a slowly progressive liver disease, the patients with moderate or severe chronic hepatitis may develop cirrhosis within a few years, the incidence of hepatocellular carcinoma is 2-5% per year. Expand
Children with hepatitis C
TLDR
There are important needs for future epidemiologic and clinical research on hepatitis C in childhood, particularly of perinatal transmission, which is now the major cause of new cases of hepatitisC in children. Expand
Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.
TLDR
The management of acute hepatitis C has to take into account the high rate of spontaneous viral clearance within 12 weeks after the onset of symptomatic disease, which is likely to clear the infection spontaneously. Expand
Epidemiology of hepatitis C virus infection.
TLDR
The high prevalence of anti-HCV detected in HCC suggests that HCV is a major co-factor in the development of HCC and again raises the issue of viral persistence and neoplastic transformation, an issue that for HBV has not yet been elucidated. Expand
Natural history of acute HCV infection in hemodialysis patients.
TLDR
The aim of this study was to analyze the evolution towards chronic hepatopathy in 19 cases of acute hepatitis C observed in hemodialysis patients from 1990 to 2001, and it is important to stress that HCV infection spontaneously cleared in 4 out of 19 patients (21%). Expand
Treatment of acute hepatitis C with interferon alfa-2b.
TLDR
Treatment of acute hepatitis C with interferon alfa-2b with treatment during the acute phase could prevent the development of chronic infection. Expand
Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy.
TLDR
These findings underscore the importance of medical procedures as risk factors in the current spread of HCV infection in Italy and show that none of the variables considered (including asymptomatic disease) were associated with increased risk of developing chronic hepatitis C. Expand
...
1
2
3
4
5
...